
Cisplatin CAS No.: 15663-27-1
We are a manufacturer based in China. We specialize in providing high-quality Cisplatin CAS No.: 15663-27-1 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category:Active Pharmaceutical Ingredients Own Brand:MT /MOQ:100KG /From China/ B2B only.
Introduction
Molecular Formula: PtCl2(NH3)2
Molecular Weight: 300.0
CAS No.: 15663-27-1
It is one of the most commonly used drugs in combined chemotherapy because of its wide anticancer spectrum, strong effect, synergistic effect with a variety of anticancer drugs, and no cross resistance.
Description
It is a yellow to orange crystalline powder. It is a heavy metal complex containing a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. It is soluble in water or saline at 1 mg/mL and in dimethylformamide at 24 mg/mL. It melts at 207°C.
Application
One of the applied platinum anticancer drugs. Its cure rate for testicular cancer is almost 100%, and it also has a good effect on ovarian cancer, lung cancer, head and neck cancer, bone cancer and other malignant tumors. Therefore, it is also known as “penicillin in anticancer drugs”.
Packing
Preserve in airtight containers.
Storage
Protect from light.
Minimum Order
One package
| Aspect | Details |
|---|---|
| Mechanism of Action | Cisplatin is a platinum-based alkylating agent that exerts its cytotoxic effects by binding to DNA, forming intra-strand and inter-strand cross-links, which inhibit DNA synthesis and cell division. This leads to apoptosis through the activation of p53, caspases, and other pro-apoptotic pathways. |
| Pharmacokinetics | Cisplatin is primarily excreted through the kidneys, with approximately 10% excreted in bile. Its initial half-life is about 20 to 30 minutes, while its terminal half-life is around 24 hours. The drug is highly protein-bound, and its clearance is significantly affected by renal function. |
| Administration | Administered intravenously, often in combination with other chemotherapeutic agents. Patients require adequate hydration before, during, and after administration to minimize nephrotoxicity. Antiemetics are typically administered prophylactically to prevent nausea and vomiting. |
| Adverse Effects | Common side effects include nephrotoxicity, neurotoxicity, ototoxicity, and gastrointestinal disturbances such as nausea and vomiting. Other potential adverse effects include hepatotoxicity, cardiotoxicity, and electrolyte imbalances. |
| Storage Conditions | Cisplatin should be stored at room temperature (15° to 30°C) and protected from light. The drug is stable in its solid form but should be prepared and used according to specific guidelines to avoid degradation. |
| Special Considerations | Dose adjustments are necessary for patients with impaired renal function. Cisplatin is often used off-label for various malignancies, including breast cancer, lung cancer, and gastrointestinal cancers, due to its broad-spectrum activity. |
| Resistance and Combination Therapy | Resistance to cisplatin can occur through mechanisms such as increased DNA repair, altered drug uptake, and overexpression of anti-apoptotic proteins. Combination therapies with other agents, such as gemcitabine or paclitaxel, are often used to enhance efficacy and overcome resistance |
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.



